SAP30BP

Across TCGA pan-cancer cohorts, SAP30BP mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated SAP30BP data layer compared with 26 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SAP30BP mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated SAP30BP expression acts as an unfavorable survival marker, although some lineages such as LUAD and PDAC show a favorable association.

LUAD, HNSC, and PDAC are the cancer types where SAP30BP mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.971	0.710	.002	41	view →
HNSC	DFS	Median	IV	0.505	0.867	<.001	32	view →
PDAC	DFS	Quartile	All	0.878	0.625	.004	6	view →
LSCC	OS	Median	All	1.000	0.926	.017	3	view →
CCRCC	DFS	Quartile	All	0.924	1.000	.025	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

SAP30BP–LUAD (OS)

Open the LUAD breakdown →